Companies founded on innovation and strong science
Serenatis Bio
Serenatis Bio is developing a pipeline of novel small-molecule drugs with unique mechanisms of action to transform the treatment landscape for obsessive-compulsive disorder (OCD), a debilitating mental illness affecting millions worldwide.
Serenatis Bio
Sector:
Biotechnology
Country:
UK/US
Year of first investment:
2025
Status:
Active
Website:
serenatisbio.com
Other investments
